Health Condition 1: M750- Adhesive capsulitis of shoulder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed case of type 2 diabetes mellitus with atleast 12 months duration having glycosylated haemoglobin (HbA1c) values between 5.5 to 12 percentage treated by diet, oral hypoglycaemic agents or insulin therapy. Stage 2 adhesive capsulitis symptoms for atleast three months with greater than 25 percent restriction in PROM of the shoulder for atleast two directions (shoulder-abduction, -flexion, internal and external rotation) compared to the opposite shoulder.
Exclusion criteria
Exclusion criteria: Patients with secondary adhesive capsulitis (e.g. traumatic adhesive capsulitis) Subject in inflammatory or chemical stage of adhesive capsulitis (If any 3 of following are present the participant would be excluded: VAS greater than 6, Night pain, redness, increased local temperature morning symptoms). Inflammatory arthritis of the shoulder, polyarthritis, rheumatoid arthritis. Bony deformity or pre-existing musculoskeletal disorders of the shoulder joint (rotator cuff injury, impingement disorder etc). History of shoulder trauma (fractures or dislocations) or ligament injury for less than 6 months. Weakness of shoulder girdle muscles associated with neurological deficits. Injection to shoulder pain, invasive procedures or surgeries in the affected shoulder. Cervical spondylosis or radiculopathy. Uncontrolled comorbidities (moderate to severe anaemia, cardiovascular impairment, nephropathy etc) affecting the study outcomes. Subjects with infections and coagulation disorders. On medication for adhesive capsulitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper Extremity Functional Index Range of Motion Visual Analog Scale Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire Capsular thickness and coracohumeral ligament (CHL) thickness Standardized Quality of Life (QoL) Assessment through SF 36Timepoint: The outcome will be assessed at baseline, 2nd week, 6th week and 10th week | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Manav Rachna International Institute of Research and Studies